リアルワールドエビデンスソリューションの市場規模、シェア、動向分析レポート：コンポーネント別、用途別、最終用途別、治療領域別、地域別、セグメント予測、2024年～2030年

リアルワールドエビデンスソリューション市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のリアルワールドエビデンスソリューションの市場規模は、2024年から2030年にかけて8.4％のCAGRを記録し、2030年までに46億米ドルに達する見込みです。

市場の主な促進要因としては、複数の分野でのRWEの用途の拡大、有利な政府規制、技術の進歩、量ベースから価値ベースのケアへのシフトなどが挙げられます。さらに、組織による戦略的イニシアチブの増加は、市場成長にプラスの影響を与えると予測されています。

2024年3月、DARWIN EU（Data Analysis &Real World Interrogation Network）は、年内に新たに10社のデータパートナーを加え、RWD研究の能力を強化する計画を発表しました。DARWIN EUは欧州13カ国にまたがる20の機関からなるネットワークで、病院、一次医療施設、健康保険データベース、登録、バイオバンクなどの多様な情報源からRWEを導き出すために、公的機関や民間団体と協力しています。

このRWEは、EMAおよびEU全域の各国規制当局の規制活動をサポートしています。DARWIN EUは、欧州全域の約1億3,000万人の患者から得られたデータを活用し、RWD研究を通じて確実なエビデンスを提供することを目指しています。特筆すべきは、このネットワークが共通のデータモデルを採用し、データの解釈を標準化する一方で、データパートナーによるローカルな保存と解析を通じてデータのプライバシーを確保していることです。このアプローチは、データ保護を優先し、大規模なマルチデータベース研究の効率的な実施を促進します。

さらに、RWEの主要な消費者は製薬企業や医療機器企業です。製品ライフサイクル全体にわたって価値を提供できるからです。それは、ライフサイエンス研究、臨床試験＆研究、市販後調査、および規制要件にわたって用途を持っています。ライフサイエンス研究において、RWEは研究者が潜在的な患者を特定し、臨床試験のための適切な組み入れ基準を作成するのを支援することにより、試験前の研究デザインに情報を提供することができます。臨床試験・研究においては、より広範な社会層に関する情報を提供し、患者報告アウトカム調査などの従来のアウトカム指標を補完することで、従来の臨床試験の限界を克服するのに役立ちます。

さらに、医療製品の設計者は、革新的で新しい治療アプローチを生み出すために、RWDとRWEを使用して臨床試験設計（例えば、実用的臨床試験、大規模単純試験）や観察研究を支援しています。このように、テクノロジーはヘルスケアの意思決定において重要な役割を果たしており、それがセグメントの成長を促進しています。例えば、2023年7月、Johnson & Johnsonは、プロスペクティブな観察レジストリ研究の結果、透視不要の心臓焼灼装置の承認を取得しました。

さらに、神経分野ではRWEを強化するためにRWD収集に注力している企業が複数あります。例えば、OM1は2023年9月、Mental Health and Neuroscience RWD Network拡大の一環として、パーキンソン病（PD）に焦点を当てた研究グレードのデータセットを発表しました。このデータセットは、OM1 Real-World Data Cloudにある70万人のPD患者のデータとともに、神経科医によって前向きに追跡された7,000人以上のPD患者のプレミアムデータを特徴としています。この包括的なデータから得られるRWEの知見は、PDペイシェントジャーニーの理解を深め、ケアとアウトカムの改善につながると期待されています。

リアルワールドエビデンスソリューション市場レポートハイライト

• コンポーネント別では、サービス分野が予測期間中の需要増加により2023年に57.7%の最大シェアで市場をリードしました。
• 用途別では、製薬企業におけるRWEソリューションの採用が増加していることから、医薬品開発・承認分野が2023年に28.7%の収益シェアで市場を独占しました。
• 最終用途別では、ヘルスケア企業が2023年に32.8%の最大シェアで市場を独占しました。この成長は、製薬会社、バイオ製薬会社、医療機器会社によって、いくつかの分野でRWEソリューションの使用が増加しているためです。
• 治療領域別では、研究機関や製薬会社によるがん治療のための治療法開発のためのRWEソリューション利用の増加により、がん分野が2023年に22.8%のシェアで市場をリードしました。
• 北米は、同地域に主要企業が存在することから、2023年の売上高シェアは43.5%で世界市場をリードしました。アジア太平洋は、2024年から2030年にかけて最も急成長する地域市場になると予測されており、これは同地域に研究開発受託機関が存在するためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 リアルワールドエビデンス（RWE）ソリューション市場の変数、動向、範囲

• 市場系統の見通し
• 市場力学
• 市場機会分析
• 市場の課題分析
• リアルワールドエビデンス（RWE）ソリューション：市場分析ツール
• 規制の枠組み
• 価格モデル分析
• ケーススタディ

第4章 リアルワールドエビデンス（RWE）ソリューション： COVID-19の影響

• COVID-19の感染率
• COVID-19が市場参入企業と実施戦略に与える影響
  • IBM
  • 医薬品開発（PPD）
  • IQVIA
• 機会分析

第5章 リアルワールドエビデンスソリューション市場：コンポーネント分析

• コンポーネントビジネス分析
• リアルワールドエビデンスソリューション市場：コンポーネント変動分析
• サービス
• データセット

第6章 リアルワールドエビデンスソリューション市場：用途分析

• 用途ビジネス分析
• リアルワールドエビデンスソリューション市場：用途変動分析
• 医薬品の開発と承認
• 医療機器の開発と承認
• 償還 / 補償・規制上の意思決定
• 市販後安全性・有害事象モニタリング

第7章 リアルワールドエビデンスソリューション市場：最終用途分析

• 最終用途ビジネス分析
• リアルワールドエビデンスソリューション市場：最終用途変動分析
• ヘルスケア企業
• ヘルスケア支払者
• ヘルスケア提供者
• その他

第8章 リアルワールドエビデンスソリューション市場：治療領域分析

• 治療領域ビジネス分析
• リアルワールドエビデンスソリューション市場：治療領域変動分析
• 腫瘍学
• 心臓病学
• 神経学
• 糖尿病
• 精神医学
• 呼吸器
• その他の治療領域

第9章 リアルワールドエビデンス（RWE）ソリューション市場：地域の市場分析、コンポーネント別、用途別、治療領域別、最終用途別、2018～2030年

• 地域別市場シェア分析、2023年・2030年
• 地域別市場のスナップショット
• 地域別市場のスナップショット
• 北米
• 欧州
• ラテンアメリカ
• 中東・アフリカ

第10章 競合分析

• 市場参加の分類
• 戦略マッピング
• 公開会社
  • ヒートマップ分析
• 非公開会社

第11章 企業プロファイル

• IQVIA Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• IBM
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• PPD, Inc.（Acquired by Thermo Fisher Scientific, Inc.）
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• Parexel International（MA）Corporation
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• PerkinElmer Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• ICON plc
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• Oracle
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• Syneos Health
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• Cegedim Health Data
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み
• Medpace
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 戦略的取り組み

第12章 戦略的提言と洞察

• 概要
• 洞察
• 提言

List of Tables

• Table 1 List of abbreviation
• Table 2 North America real world evidence solutions market, by region, 2018 - 2030 (USD Million)
• Table 3 North America real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 4 North America real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 5 North America real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 8 U.S. real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 9 U.S. real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 11 Canada real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 12 Canada real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 13 Canada real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 14 Canada real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 15 Europe real world evidence solutions market, by region, 2018 - 2030 (USD Million)
• Table 16 Europe real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 17 Europe real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 18 Europe real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 20 Germany real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 21 Germany real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 22 Germany real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 23 Germany real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 24 UK real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 25 UK real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 26 UK real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 27 UK real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 28 France real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 29 France real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 30 France real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 31 France real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 33 Italy real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 35 Italy real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 36 Spain real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 37 Spain real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 38 Spain real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 39 Spain real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 40 Denmark real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 41 Denmark real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 42 Denmark real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 43 Denmark real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 44 Sweden real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 45 Sweden real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 46 Sweden real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 47 Sweden real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 48 Norway real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 49 Norway real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 50 Norway real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 51 Norway real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific real world evidence solutions market, by region, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 57 China real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 58 China real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 59 China real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 60 China real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 61 Japan real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 62 Japan real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 63 Japan real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 64 Japan real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 65 India real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 66 India real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 67 India real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 68 India real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 69 South Korea real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 70 South Korea real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 71 South Korea real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 72 South Korea real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 73 Australia real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 74 Australia real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 75 Australia real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 76 Australia real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 77 Thailand real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 78 Thailand real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 79 Thailand real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 80 Thailand real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 81 Latin America real world evidence solutions market, by region, 2018 - 2030 (USD Million)
• Table 82 Latin America real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 83 Latin America real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 84 Latin America real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 85 Latin America real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 86 Brazil real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 87 Brazil real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 88 Brazil real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 89 Brazil real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 90 Mexico real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 91 Mexico real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 92 Mexico real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 93 Mexico real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 94 Argentina real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 95 Argentina real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 96 Argentina real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 97 Argentina real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 98 MEA real world evidence solutions market, by region, 2018 - 2030 (USD Million)
• Table 99 MEA real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 100 MEA real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 101 MEA real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 102 MEA real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 103 South Africa real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 104 South Africa real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 105 South Africa real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 106 South Africa real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 111 Israel real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 112 Israel real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 113 Israel real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 114 Israel real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 115 UAE real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 116 UAE real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 117 UAE real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 118 UAE real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 119 Kuwait real world evidence solutions market, by component, 2018 - 2030 (USD Million)
• Table 120 Kuwait real world evidence solutions market, by application, 2018 - 2030 (USD Million)
• Table 121 Kuwait real world evidence solutions market, by end use, 2018 - 2030 (USD Million)
• Table 122 Kuwait real world evidence solutions market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Commodity flow analysis
• Fig. 10 Ancillary market outlook
• Fig. 11 Market trends & outlook
• Fig. 12 Market driver relevance analysis (Current & future impact)
• Fig. 13 Market restraint relevance analysis (Current & future impact)
• Fig. 14 Real world evidence solutions market: PORTER's five forces analysis
• Fig. 15 Real world evidence solutions market: PESTEL analysis
• Fig. 16 Real world evidence solutions market component outlook: Key takeaways
• Fig. 17 Real world evidence solutions market: Component movement analysis
• Fig. 18 Services market, 2018 - 2030 (USD Million)
• Fig. 19 Data sets market, 2018 - 2030 (USD Million)
• Fig. 20 Clinical settings data market, 2018 - 2030 (USD Million)
• Fig. 21 Claims data market, 2018 - 2030 (USD Million)
• Fig. 22 Pharmacy market, 2018 - 2030 (USD Million)
• Fig. 23 Patient-powered data market, 2018 - 2030 (USD Million)
• Fig. 24 Real world evidence solutions market application outlook: Key takeaways
• Fig. 25 Real world evidence solutions market: Application movement analysis
• Fig. 26 Drug development & approvals market, 2018 - 2030 (USD Million)
• Fig. 27 Medical device development & approvals market, 2018 - 2030 (USD Million)
• Fig. 28 Reimbursement/coverage & regulatory decision-making market, 2018 - 2030 (USD Million)
• Fig. 29 Post-market safety & adverse events monitoring market, 2018 - 2030 (USD Million)
• Fig. 30 Real world evidence solutions market end-use outlook: Key takeaways
• Fig. 31 Real world evidence solutions market: End use movement analysis
• Fig. 32 Healthcare companies market, 2018 - 2030 (USD Million)
• Fig. 33 Clinical research market, 2018 - 2030 (USD Million)
• Fig. 34 Commercial research market, 2018 - 2030 (USD Million)
• Fig. 35 HEOR market, 2018 - 2030 (USD Million)
• Fig. 36 Others market, 2018 - 2030 (USD Million)
• Fig. 37 Healthcare payers market, 2018 - 2030 (USD Million)
• Fig. 38 Healthcare providers market, 2018 - 2030 (USD Million)
• Fig. 39 Others market, 2018 - 2030 (USD Million)
• Fig. 40 Real world evidence solutions market therapeutic area outlook: Key takeaways
• Fig. 41 Real world evidence solutions market: Therapeutic area movement analysis
• Fig. 42 Oncology market, 2018 - 2030 (USD Million)
• Fig. 43 Cardiology market, 2018 - 2030 (USD Million)
• Fig. 44 Neurology market, 2018 - 2030 (USD Million)
• Fig. 45 Diabetes market, 2018 - 2030 (USD Million)
• Fig. 46 Psychiatry market, 2018 - 2030 (USD Million)
• Fig. 47 Respiratory market, 2018 - 2030 (USD Million)
• Fig. 48 Other therapeutic areas market, 2018 - 2030 (USD Million)
• Fig. 49 Regional outlook, 2023 & 2030
• Fig. 50 Regional marketplace: Key takeaways
• Fig. 51 Regional marketplace: Key takeaways
• Fig. 52 North America real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 53 U.S country dynamics
• Fig. 54 U.S. Real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 55 Canada country dynamics
• Fig. 56 Canada real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 57 Europe real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 58 Germany country dynamics
• Fig. 59 Germany real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 60 France country dynamics
• Fig. 61 France real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 62 UK country dynamics
• Fig. 63 UK real rorld evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 64 Italy country dynamics
• Fig. 65 Italy real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 66 Spain country dynamics
• Fig. 67 Spain real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 68 Denmark country dynamics
• Fig. 69 Denmark real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 70 Sweden country dynamics
• Fig. 71 Sweden real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 72 Norway country dynamics
• Fig. 73 Norway real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 74 Asia Pacific real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 75 Japan country dynamics
• Fig. 76 Japan real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 77 China country dynamics
• Fig. 78 China real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 79 India country dynamics
• Fig. 80 India real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 81 Australia country dynamics
• Fig. 82 Australia real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 83 South Korea country dynamics
• Fig. 84 South Korea real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 85 Thailand country dynamics
• Fig. 86 Thailand real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 87 Latin America real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 88 Brazil country dynamics
• Fig. 89 Brazil real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 90 Mexico country dynamics
• Fig. 91 Mexico real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 92 Argentina country dynamics
• Fig. 93 Argentina real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 94 MEA real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 95 South Africa country dynamics
• Fig. 96 South Africa real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 97 Saudi Arabia country dynamics
• Fig. 98 Saudi Arabia Real World Evidence Solutions market, 2018 - 2030 (USD Million)
• Fig. 99 Israel country dynamics
• Fig. 100 Israel real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 101 UAE country dynamics
• Fig. 102 UAE real world evidence Solutions market, 2018 - 2030 (USD Million)
• Fig. 103 Kuwait country dynamics
• Fig. 104 Kuwait real world evidence solutions market, 2018 - 2030 (USD Million)
• Fig. 105 Market participant categorization
• Fig. 106 Real world evidence solutions market: Strategy mapping
• Fig. 107 Real world evidence solutions: Heat map analysis
• Fig. 108 Case studies of RWE impact across opportunity areas

Real World Evidence Solutions Market Growth & Trends:

The global real world evidence solutions market size is expected to reach USD 4.6 billion by 2030, registering a CAGR of 8.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key driving factors of the market include growing applications of RWE in several fields, favorable government regulations, technological advancements, and a shift from volume to value-based care. Furthermore, a growing number of strategic initiatives by organizations are anticipated to positively influence market growth.

In March 2024, DARWIN EU, the Data Analysis & Real World Interrogation Network, announced plans to enhance its capacity for RWD studies by adding 10 new data partners within the year. With a network of 20 institutions spanning 13 European countries, DARWIN EU collaborates with public & private entities to derive RWE from diverse sources, including hospitals, primary care facilities, health insurance databases, registries, and biobanks.

This RWE supports regulatory activities of the EMA and national regulators across the EU. Leveraging data from approximately 130 million patients across Europe, DARWIN EU aims to deliver robust evidence through RWD studies. Notably, the network employs a common data model to standardize data interpretation while ensuring data privacy through local storage and analysis by data partners. This approach prioritizes data protection and facilitates the efficient execution of large-scale, multi-database studies.

Furthermore, major consumers of RWE are pharmaceutical and medical device companies. This is because it can provide value across the entire product lifecycle. It has applications across life science research, clinical trials & studies, post-market surveillance, and regulatory requirements. In life science research, RWE can inform pretrial study design by assisting researchers in identifying potential patients and creating proper inclusion criteria for clinical trials. Within clinical trials & studies, it helps overcome traditional clinical trials' limitations by providing information about a broader cross-section of society and supplementing traditional outcome measures, such as patient-reported outcome surveys.

Moreover, medical product designers are using RWD & RWE to aid clinical trial designing (e.g., pragmatic clinical trials, large simple trials) and observational studies to produce innovative, new treatment approaches. Thus, technology plays a significant role in healthcare decisions, which, in turn, promotes segment growth. For instance, in July 2023, Johnson & Johnson gained approval for certain cardiac ablation devices for fluoroscopy-free use following a prospective observational registry study-an instance of the agency employing RWE in device reviews.

In addition, several companies are focusing on RWD collection to enhance RWE in the neurology sector. For instance, in September 2023, OM1 announced a curated research-grade dataset focused on Parkinson's disease (PD) as part of its Mental Health and Neuroscience RWD Network expansion. This dataset features premium data from over 7,000 individuals with PD, tracked prospectively by neurologists, along with data from 700,000 PD patients in the OM1 Real-World Data Cloud. The RWE insights from this comprehensive data are anticipated to enhance understanding of PD patient journeys, leading to improved care & outcomes.

Real World Evidence Solutions Market Report Highlights:

• Based on component, the services segment led the market with the largest share of 57.7% in 2023 owing to its increasing demand over the forecast period
• Based on application, the drug development and approvals segment dominated the market with a revenue share of 28.7% in 2023 owing to the rising adoption of RWE solutions in pharmaceutical companies for this application
• Based on end-use, healthcare companies dominated the market with the largest share of 32.8% in 2023. The growth is due to growing use of RWE solutions in several fields by pharmaceutical, biopharmaceutical, and medical device companies
• Based on therapeutic area, the oncology segment led the market with a share of 22.8% in 2023 owing to increased use of RWE solutions to develop therapies for cancer care by research organizations and pharmaceutical companies
• North America led the global market with a revenue share of 43.5% in 2023 owing to the presence of major players in the region. Asia Pacific is expected to be the fastest-growing regional market from 2024 to 2030 owing to the presence of contract research organizations in the region

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates & Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research:
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Consensus-based Estimates & Forecasting
    • 1.6.1.1 Commodity Flow Analysis
    • 1.6.1.2 Top-down Market Estimation
    • 1.6.1.3 Country-based Segment Share Calculation
  • 1.6.2 Multivariate Analysis
  • 1.6.3 Real World Evidence Solutions Market: Cagr Calculation
• 1.7 List Of Secondary Sources
• 1.8 Objectives
  • 1.8.1 Objective - 1
  • 1.8.2 Objective - 2

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Real World Evidence (Rwe) Solutions Market Variables Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Favorable Government Regulations
    • 3.2.1.2 Rising Applications Of Real-world Evidence (RWE) In Various Fields
    • 3.2.1.3 Technological Advancements
    • 3.2.1.4 Increasing Initiatives By Organizations
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Lack Of Access To Healthcare Data
• 3.3 Market Opportunity Analysis
  • 3.3.1 Gap Between Research And Practice
• 3.4 Market Challenges Analysis
  • 3.4.1 Issues With Rwe Validation, Operations, And Technologies
• 3.5 Real World Evidence (Rwe) Solutions: Market Analysis Tools
  • 3.5.1 Industry Analysis - Porter's
  • 3.5.2 Industry Analysis - Pestle
• 3.6 Regulatory Framework
  • 3.6.1 North America
  • 3.6.2 Asia Pacific
  • 3.6.3 Europe - Regulatory Framework
• 3.7 Pricing Model Analysis
  • 3.7.1 Pay Per Usage
  • 3.7.2 Pay Per Patient Record
  • 3.7.3 Annual/monthly Subscription
• 3.8 Case Study
  • 3.8.1 Case Study 1:- OM1 Partnered With Healthcare Facilities To Collect Medical Data At A Clinical Level
  • 3.8.2 Case Study 2:- Verana Health

Chapter 4 Real World Evidence (Rwe) Solutions: COVID-19 Impact

• 4.1 COVID-19 Disease Prevalence
• 4.2 Impact Of COVID-19 On Market Players And Strategies Implemented
  • 4.2.1 Ibm
  • 4.2.2 Pharmaceutical Product Development (PPD)
  • 4.2.3 Iqvia
• 4.3 Opportunity Analysis

Chapter 5 Real World Evidence Solutions Market: Component Analysis

• 5.1 Component Business Analysis
• 5.2 Real World Evidence Solutions Market: Component Movement Analysis
• 5.3 Services
  • 5.3.1 Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.4 Data Sets
  • 5.4.1 Data Sets Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2 Clinical Settings Data
    • 5.4.2.1 Clinical Settings Data Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3 Claims Data
    • 5.4.3.1 Claims Data Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4 Pharmacy Data
    • 5.4.4.1 Pharmacy Data Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.5 Patient-powered Data
    • 5.4.5.1 Patient-powered Data Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Real World Evidence Solutions Market: Application Analysis

• 6.1 Application Business Analysis
• 6.2 Real World Evidence Solutions Market: Application Movement Analysis
• 6.3 Drug Development & Approvals
  • 6.3.1 Drug Development & Approvals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.4 Medical Device Development & Approvals
  • 6.4.1 Medical Device Development & Approvals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5 Reimbursement/coverage & Regulatory Decision-making
  • 6.5.1 Reimbursement/coverage & Regulatory Decision-making Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.6 Post-market Safety & Adverse Events Monitoring
  • 6.6.1 Post-market Safety & Adverse Events Monitoring Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Real World Evidence Solutions Market: End Use Analysis

• 7.1 End Use Business Analysis
• 7.2 Real World Evidence Solutions Market: End Use Movement Analysis
• 7.3 Healthcare Companies
  • 7.3.1 Healthcare Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2 Clinical Research Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3 Commercial Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4 Heor Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.4 Healthcare Payers
  • 7.4.1 Healthcare Payers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5 Healthcare Providers
  • 7.5.1 Healthcare Providers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6 Others
  • 7.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Real World Evidence Solutions Market: Therapeutic Area Analysis

• 8.1 Therapeutic Area Business Analysis
• 8.2 Real World Evidence Solutions Market: Therapeutic Area Movement Analysis
• 8.3 Oncology
  • 8.3.1 Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.4 Cardiology
  • 8.4.1 Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5 Neurology
  • 8.5.1 Neurology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6 Diabetes
  • 8.6.1 Diabetes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7 Psychiatry
  • 8.7.1 Psychiatry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8 Respiratory
  • 8.8.1 Respiratory Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.9 Other Therapeutic Areas
  • 8.9.1 Other Therapeutic Areas Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9 Real World Evidence (Rwe) Solutions Market: Regional Market Analysis, By Component, Application, Therapeutic Area, And End Use 2018 - 2030 (USD Million)

• 9.1 Regional Market Share Analysis, 2023 & 2030
• 9.2 Regional Market Snapshot
• 9.3 Regional Market Snapshot
• 9.4 North America
  • 9.4.1 North America Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2 U.S.
    • 9.4.2.1 Country Dynamics
    • 9.4.2.2 U.S. Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3 Canada
    • 9.4.3.1 Country Dynamics
    • 9.4.3.2 Canada Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.5 Europe
  • 9.5.1 Europe Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2 Germany
    • 9.5.2.1 Country Dynamics
    • 9.5.2.2 Germany Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3 France
    • 9.5.3.1 Country Dynamics
    • 9.5.3.2 France Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4 Uk
    • 9.5.4.1 Country Dynamics
    • 9.5.4.2 Uk Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5 Italy
    • 9.5.5.1 Country Dynamics
    • 9.5.5.2 Italy Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6 Spain
    • 9.5.6.1 Country Dynamics
    • 9.5.6.2 Spain Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7 Denmark
    • 9.5.7.1 Country Dynamics
    • 9.5.7.2 Denmark Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8 Sweden
    • 9.5.8.1 Country Dynamics
    • 9.5.8.2 Sweden Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9 Norway
    • 9.5.9.1 Country Dynamics
    • 9.5.9.2 Norway Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.10 Asia Pacific Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.11 Japan
    • 9.5.11.1 Country Dynamics
    • 9.5.11.2 Japan Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.12 China
    • 9.5.12.1 Country Dynamics
    • 9.5.12.2 China Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.13 India
    • 9.5.13.1 Country Dynamics
    • 9.5.13.2 India Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.14 Australia
    • 9.5.14.1 Country Dynamics
    • 9.5.14.2 Australia Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.15 South Korea
    • 9.5.15.1 Country Dynamics
    • 9.5.15.2 South Korea Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.16 Thailand
    • 9.5.16.1 Country Dynamics
    • 9.5.16.2 Thailand Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6 Latin America
  • 9.6.1 Latin America Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2 Brazil
    • 9.6.2.1 Country Dynamics
    • 9.6.2.2 Brazil Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3 Mexico
    • 9.6.3.1 Country Dynamics
    • 9.6.3.2 Mexico Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4 Argentina
    • 9.6.4.1 Country Dynamics
    • 9.6.4.2 Argentina Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.7 Mea
  • 9.7.1 Mea Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2 South Africa
    • 9.7.2.1 Country Dynamics
    • 9.7.2.2 South Africa Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3 Saudi Arabia
    • 9.7.3.1 Country Dynamics
    • 9.7.3.2 Saudi Arabia Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.4 Israel
    • 9.7.4.1 Country Dynamics
    • 9.7.4.2 Israel Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.5 Uae
    • 9.7.5.1 Country Dynamics
    • 9.7.5.2 Uae Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.6 Kuwait
    • 9.7.6.1 Country Dynamics
    • 9.7.6.2 Kuwait Real World Evidence Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Competitive Analysis

• 10.1 Market Participation Categorization
• 10.2 Strategic Mapping
• 10.3 Public Companies
  • 10.3.1 Heat Map Analysis
• 10.4 Private Companies

Chapter 11 Company Profiles

• 11.1 IQVIA Inc.
  • 11.1.1 Company Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Benchmarking
  • 11.1.4 Strategic Initiatives
• 11.2 IBM
  • 11.2.1 Company Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Benchmarking
  • 11.2.4 Strategic Initiatives
• 11.3 PPD, Inc. (Acquired by Thermo Fisher Scientific, Inc.)
  • 11.3.1 Company Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Benchmarking
  • 11.3.4 Strategic Initiatives
• 11.4 Parexel International (MA) Corporation
  • 11.4.1 Company Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Benchmarking
  • 11.4.4 Strategic Initiatives
• 11.5 PerkinElmer Inc.
  • 11.5.1 Company Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Benchmarking
  • 11.5.4 Strategic Initiatives
• 11.6 ICON plc
  • 11.6.1 Company Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Benchmarking
  • 11.6.4 Strategic Initiatives
• 11.7 Oracle
  • 11.7.1 Company Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Benchmarking
  • 11.7.4 Strategic Initiatives
• 11.8 Syneos Health
  • 11.8.1 Company Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Benchmarking
  • 11.8.4 Strategic Initiatives
• 11.9 Cegedim Health Data
  • 11.9.1 Company Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Benchmarking
  • 11.9.4 Strategic Initiatives
• 11.10 Medpace
  • 11.10.1 Company Overview
  • 11.10.2 Financial Performance
  • 11.10.3 Product Benchmarking
  • 11.10.4 Strategic Initiatives

Chapter 12 Strategic Recommendation And Insights

• 12.1 Overview
• 12.2 Insights
• 12.3 Recommendation